We’ve moved

The Rosalind and Morris Goodman Cancer Institute can now be found at www.goodmancancer.ca

Visit the new site

 

Home

Four projects from GCI members were selected during the Cancer Research Society’s annual competition

The Cancer Research Society (CRS) is awarding 90 new research grants valued at $10.8 million as part of its annual competition. The grants are awarded to some of the most promising cancer research projects in Canada.
Portraits of the 4 GCI members who received CRS funding, with the CRS logo
Romane Monnet | 7 Oct 2022

As part of its annual competition, the CRS receives hundreds of applications from researchers and clinicians throughout Canada who are seeking a $120,000 2-year grant for a cancer research project. The financial support is awarded to projects retained through a rigorous selection process conducted via peer-evaluation committees, which this year were composed of 85 researchers and clinicians who generously volunteered their time.   

We are proud to announce that four projects from GCI members were selected: 

Causes and prevention - the most effective approach to reducing the risk of developing the disease 

  1. Prof. Michel Tremblay: PTP-PRL2 (PTP4A2) in lymphoangiogenesis and metastasis: a novel target in cancer 

  1. Prof. Yojiro Yamanaka: Investigating ovarian cancer susceptibility of FANCI L604F in mouse ovarian cancer models 

Treatment – the development of new treatments, including targeted or personalized therapies 

  1. Prof. Luke McCaffrey: Identifying tamoxifen-persistent cells to predict ER+ breast cancer outcomes 

  1. Dr. Jonathan Spicer: Disentangling radiation-resistant lung cancer by targeting neutrophil extracellular traps 

Congratulations to the four teams!  

Back to top